Classement en actions
#41228
GENinCode Plc specializes in the creation and commercialization of advanced... GENinCode Plc specializes in the creation and commercialization of advanced genetic tests designed to forecast potential health risks based on an individual's DNA. Operating in both the United Kingdom and internationally, their predictive technology empowers individuals and medical professionals alike with proactive health management and targeted intervention strategies. The company's sophisticated molecular diagnostics leverage a combination of clinical algorithms and artificial intelligence to deliver precise patient risk assessments, thereby anticipating the onset of various diseases. Among their specialized tests are: Cardio inCode: A patented genetic assay designed to guide individuals in cardiovascular prevention. Lipid inCode: A genetic diagnostic tool that analyzes seven specific genes associated with familial hypercholesterolemia. SUDD inCode: A genetic test to identify the underlying causes of sudden cardiac death and inherited heart conditions. Thrombo inCode: This test assesses 12 genetic variants linked to hereditary thrombophilia and the general risk of thrombosis (blood clots). Thrombo inCode Reproductive Health: Offering crucial insights into thrombophilia risks particularly relevant to prospective pregnancies. Established in 2018, GENinCode Plc maintains its headquarters in Oxford, United Kingdom.
Prix de l'action
$0.01206398
Capitalisation boursière
$33.74K
Changement (1 jour)
-1.49%
Changement (1 an)
-40.77%
Échange GENinCode plc (GENI)
Nombre d'actions en circulation pour GENinCode plc (GENI)
Nombre d'actions en circulation au August 2026: 0
Selon les derniers rapports financiers et le cours de l'action de GENinCode plc, le nombre actuel d'actions en circulation est de 0. À la fin de August 2026, l'entreprise avait 0 actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de GENinCode plc (GENI) de 2026 à 2026
Actions en circulation à la fin de chaque année
| Année |
Actions en circulation |
Changez |
|
Pas assez de données pour les dates fournies. |
Actions en circulation pour des entreprises similaires ou concurrentes
| Entreprise |
Actions en circulation |
Différence |
Pays |
|
|
371.00M |
-
|
US
|
|
|
705.30M |
-
|
US
|
|
|
- |
-
|
CN
|
|
|
80.10M |
-
|
US
|
|
|
143.28M |
-
|
US
|
